Drug intelligence / Profile preview

fac-[Re(phen)(CO)3(MMPP)]

Development stage: Unknown
Modality: DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Overview

fac-[Re(phen)(CO)3(MMPP)] is an organometallic complex belonging to the class of Rhenium(I) tricarbonyl complexes. These complexes are widely studied for their potential biological applications, including anti-proliferative activity against cancer cells and their utility in cell imaging due to their luminescent properties. While the broader class of Rhenium(I) tricarbonyl complexes has shown promise as potential anti-cancer drugs and organelle probes, specific details regarding the mechanism of action, efficacy, or cellular localization of this exact compound, fac-[Re(phen)(CO)3(MMPP)], are not available in the provided context.

Beyond the preview

Go deeper on fac-[Re(phen)(CO)3(MMPP)].

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fac-[Re(phen)(CO)3(MMPP)].

Explore the full profile